Effect of the treatment with methylprednisolone on the cerebrospinal fluid and serum levels of CCL2 and CXCL10 chemokines in patients with active multiple sclerosis. [electronic resource]
Producer: 20061003Description: 109-13 p. digitalISSN:- 0001-6314
- Adult
- Anti-Inflammatory Agents -- pharmacology
- Biomarkers -- blood
- Chemokine CCL2 -- blood
- Chemokine CXCL10
- Chemokines, CXC -- blood
- Chemotaxis, Leukocyte -- immunology
- Controlled Clinical Trials as Topic
- Down-Regulation -- drug effects
- Female
- Humans
- Male
- Methylprednisolone -- pharmacology
- Middle Aged
- Multiple Sclerosis, Relapsing-Remitting -- drug therapy
- Predictive Value of Tests
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.